These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5096683)

  • 1. [Preliminary evaluation of the toxicity of C-283 compound used intravenously].
    Kwaśniewska-Rokicińska ; Swiecki J
    Pol Tyg Lek; 1971 Jul; 26(28):1086-8. PubMed ID: 5096683
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic efficacy of compound C-283 in patients with mammary carcinoma.
    Kwaśniewska-Rokicińska ; Swiecki J; Wieczorkiewicz A
    Arch Immunol Ther Exp (Warsz); 1973; 21(6):863-70. PubMed ID: 4784637
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical pharmacologic investigations on 1-nitro-9-(dimethylaminopropylamino)-acridine and its N-oxide. I. Acute and subchronic activity.
    Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):399-417. PubMed ID: 5055687
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of C-283 in the treatment of skin cancer].
    Swiecki J; Kwaśniewska-Rokicińska ; Franek K
    Przegl Dermatol; 1972; 59(6):765-70. PubMed ID: 4643580
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic studies on 1-nitro-9-(5-dimethylaminopentylamino)-acridine and 1-nitro-10(3-dimethylaminopropyl)-acridone. II. Chronic action.
    Patkowski J; Kowalczyk-Bronisz SH; Szaga B; Teodorczyk J; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):797-820. PubMed ID: 4771984
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of the acridane derivative, clomacran phosphate and trifluoperazine in schizophrenia.
    Angus JW; Deutsch LJ; Edwards JG; Simpson GM
    Behav Neuropsychiatry; 1969 Apr; 1(1):13-8. PubMed ID: 4920977
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical studies of cancer patients treated with acridine derivative (C-283). IV. Changes in the levels of serum haptoglobin and sialic acid.
    Dobryszycka W; Osada J; Gerber J; Jablonski K
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):271-9. PubMed ID: 4790848
    [No Abstract]   [Full Text] [Related]  

  • 8. [C-283 in treatment of peritoneal and pleural effusions in patients with ovarian carcinoma].
    Kwaśniewska-Rokicińska
    Pol Tyg Lek; 1971 Mar; 26(10):361-3. PubMed ID: 5102483
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic studies on 1-nitro-9-(5-dimethyl-aminopentylamino)-acridine and 1-nitro-10-(3-dimethylaminopropyl)-acridone. 1. Acute and subchronic action.
    Patkowski J; Kowalczyk-Bronisz SH; Szaga B; Teodorczyk J; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):775-95. PubMed ID: 4771983
    [No Abstract]   [Full Text] [Related]  

  • 10. [Early changes in lung tissue following isolation perfusion with a cytostatic of Polish production C-283].
    Gacyk W
    Pol Przegl Chir; 1974 Jun; 46(6):715-22. PubMed ID: 4840924
    [No Abstract]   [Full Text] [Related]  

  • 11. Preclinical pharmacologic studies on 1-nitro-9-(dimethylaminopropylamino)-acridine and its n-oxide. II. Chronic action.
    Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):419-44. PubMed ID: 5055688
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. II. Chronic action.
    Pelczarska A; KPOWALCZUK-Bronisz H; Blaszcyk B; Gieldanowski J; Patkowski J
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):843-62. PubMed ID: 4451446
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
    Grem JL; Harold N; Keith B; Chen AP; Kao V; Takimoto CH; Hamilton JM; Pang J; Pace M; Jasser GB; Quinn MG; Monahan BP
    Clin Cancer Res; 2002 Jul; 8(7):2149-56. PubMed ID: 12114415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isophosphamide: study of its toxicity and immediate results with large doses].
    Araujo CE; Tagle JC
    Prensa Med Argent; 1971 Dec; 58(40):1953-8. PubMed ID: 5137763
    [No Abstract]   [Full Text] [Related]  

  • 15. One-year trial of the antipsychotic acridan compound, SK AND F 14336.
    Bishop MP; Mason LB; Gallant DM
    Behav Neuropsychiatry; 1969 Jun; 1(3):4-9. PubMed ID: 5398104
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934).
    LoRusso P; Foster BJ; Poplin E; McCormick J; Kraut M; Flaherty L; Heilbrun LK; Valdivieso M; Baker L
    Clin Cancer Res; 1995 Dec; 1(12):1487-93. PubMed ID: 9815948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
    Plaxe SC; Blessing JA; Bookman MA; Creasman WT
    Gynecol Oncol; 2002 Jan; 84(1):32-5. PubMed ID: 11748972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on 1-nitro-9-alkyl acridine derivatives. II. Chronic action.
    Kowalczyk-Bronisz SH; Blaszczyk B; Gieldonowski J; Patkowski J; Pelczarska A
    Arch Immunol Ther Exp (Warsz); 1975; 23(3):415-34. PubMed ID: 1217966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estract in advanced prostatic carcinoma.
    Alfthan OS; Rusk J
    Ann Chir Gynaecol Fenn; 1969; 58(3):234-40. PubMed ID: 5380304
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of Ledakrin on renal and hepatic functions.
    Bratkowska-Seniów B; Kaniak T; Stumpf A; Wahl-Mugeńska M; Wojnarska J
    Mater Med Pol; 1976; 8(3):316-22. PubMed ID: 1011874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.